We also observed that 24.1% of NRAS-mutant tumors proved to be nodular melanoma, while 16.7% of BRAF-mutant and 17.9% of double-wild-type tumors belonged to that histological category (Table 4). This evidence concerns the gene BRAF and nodular malignant melanoma.